Solventum Co. (NYSE:SOLV) Shares Sold by Wedbush Securities Inc.

Wedbush Securities Inc. reduced its position in shares of Solventum Co. (NYSE:SOLV) by 5.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,040 shares of the company’s stock after selling 230 shares during the period. Wedbush Securities Inc.’s holdings in Solventum were worth $267,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of SOLV. Quantinno Capital Management LP acquired a new stake in Solventum during the third quarter worth about $448,000. Kovitz Investment Group Partners LLC purchased a new position in Solventum during the third quarter worth about $356,000. EP Wealth Advisors LLC purchased a new position in Solventum during the third quarter worth about $355,000. XTX Topco Ltd purchased a new position in Solventum during the third quarter worth about $416,000. Finally, Orion Portfolio Solutions LLC purchased a new position in shares of Solventum in the third quarter valued at approximately $1,316,000.

Wall Street Analyst Weigh In

Several research firms have recently commented on SOLV. Wells Fargo & Company raised their price objective on shares of Solventum from $73.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, February 28th. Piper Sandler raised their target price on shares of Solventum from $75.00 to $84.00 and gave the company a “neutral” rating in a report on Friday, February 28th. The Goldman Sachs Group raised their target price on shares of Solventum from $63.00 to $71.00 and gave the company a “sell” rating in a report on Monday, March 3rd. Mizuho raised their target price on shares of Solventum from $70.00 to $82.00 and gave the company a “neutral” rating in a report on Monday, March 3rd. Finally, Morgan Stanley raised their target price on shares of Solventum from $73.00 to $80.00 and gave the company an “equal weight” rating in a report on Wednesday, March 5th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $79.86.

Solventum Stock Performance

Shares of Solventum stock opened at $68.61 on Thursday. The firm’s fifty day simple moving average is $74.52 and its 200-day simple moving average is $71.75. The stock has a market capitalization of $11.87 billion and a price-to-earnings ratio of 24.95. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $85.92. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.